This study builds directly on my previous first-author work published in Biomaterials (2020), in which I demonstrated that an amino acid-based compound, AAC2, improves glycemic control and anxiety-like behavior in diabetic mice through insulin-independent activation of the leptin receptor and atypical PKC pathways.
J. Nanobiotechnol.2026-01-05
![[에펜도르프] 2026 상반기 특별 프로모션 : 프리미엄 에펜도르프 제품을 좋은 혜택으로 만날 수 있는 기회!](/app/board/attach/image/1348816_1772455401000.do?)
